RT Journal Article
SR Electronic
T1 Effect of COVID-19 on <sup>18</sup>F-FDG PET/CT: Is there a need for considering COVID-19 status before planning <sup>18</sup>F-FDG PET/CT for oncological evaluation?
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP jnmt.121.262145
DO 10.2967/jnmt.121.262145
A1 Anwin Joseph Kavanal
A1 Santosh Ranjan Jena
A1 Rajender Kumar
A1 Chandan Krushna Das
A1 Sunil Kumar
A1 Bhagwant Rai Mittal
YR 2021
UL http://tech.snmjournals.org/content/early/2021/07/09/jnmt.121.262145.abstract
AB Incidental detection of coronavirus disease-2019 (COVID-19) related lung changes in 18F-FDG PET/CT of oncology patients have been increasingly reported. Most of the case reports/series stressed upon the retrospective diagnosis of COVID-19 with the help of 18F-FDG PET/CT lung findings. In this case report, we introduce a different aspect of COVID-19 related lung changes in 18F-FDG PET/CT, interfering with the evaluation of metastatic lung lesions in patients with renal cell carcinoma.